Suppr超能文献

多发性肌炎/皮肌炎再入院:全国再入院数据库分析。

Polymyositis/dermatomyositis readmissions: analysis of the nationwide readmission database.

机构信息

Department of Internal Medicine, Piedmont Athens Regional, Athens, GA, USA.

Division of Rheumatology, Loma Linda University Health, Loma Linda, USA.

出版信息

Clin Rheumatol. 2023 Oct;42(10):2833-2839. doi: 10.1007/s10067-023-06690-w. Epub 2023 Jul 5.

Abstract

BACKGROUND

There is a scarcity of national population-based studies on polymyositis (PM)/dermatomyositis (DM) readmissions in the USA. In this study, we aim to describe the rates, reasons for readmissions, and characteristics of readmissions for adults hospitalized for PM/DM in the USA.

METHODS

We analyzed the 2018 Nationwide Readmissions Database (NRD). We included index hospitalizations for all adult DM/PM patients with a principal diagnosis of PM/DM using ICD-10 codes. We excluded elective and traumatic readmissions. Using a "rank" command in STATA, the most common specific principal diagnosis of readmissions was outlined. Chi-square tests were used to compare baseline characteristics between readmissions and index hospitalizations. STATA 16 was used for analysis.

RESULTS

A total of 1610, 1286, and 842 index hospitalizations with a principal diagnosis of PM/DM, that were discharged alive, were included in the 30-, 90-, and 180-day readmission analysis, respectively. Among these, 193 (12%), 276 (21.5%), and 240 (28.5%) were readmitted within 30, 90, and 180 days, respectively. PM and sepsis were the most common reasons for reasons across the 3 timeframes. 30-day readmissions were responsible for an aggregate of 4.1 million US dollars in total hospital cost and 1518 hospital days in 2018. Compared to index hospitalizations, 30-day readmissions have higher Charlson Comorbidity Index scores, severe-extreme loss of function, obesity, and deep venous thrombosis.

CONCLUSION

About a third of PM/DM hospitalized patients are readmitted within 180 days. Readmissions constitute a significant economic burden to the health care system. PM and sepsis are the main reasons for readmissions. Key points • About a third of polymyositis (PM)/dermatomyositis (DM) hospitalized patients are readmitted within 180 days • PM and sepsis are the main reasons for readmissions. • Readmissions of PM/DM Patients constitute a significant economic burden to the health care system. • Compared to index hospitalizations, 30-day readmissions have higher Charlson comorbidity index scores, severe-extreme loss of function, obesity, and deep venous thrombosis.

摘要

背景

美国缺乏全国性的基于人群的多发性肌炎(PM)/皮肌炎(DM)再入院研究。本研究旨在描述美国因 PM/DM 住院的成年人的再入院率、再入院原因和再入院特征。

方法

我们分析了 2018 年全国再入院数据库(NRD)。我们使用 ICD-10 代码纳入所有主要诊断为 PM/DM 的成年 DM/PM 患者的索引住院。我们排除了选择性和创伤性再入院。使用 STATA 中的“rank”命令,概述了最常见的特定再入院主要诊断。使用卡方检验比较再入院和索引住院的基线特征。使用 STATA16 进行分析。

结果

共纳入 1610 例、1286 例和 842 例主要诊断为 PM/DM 的出院后存活的索引住院患者,分别进行 30 天、90 天和 180 天的再入院分析。其中,分别有 193 例(12%)、276 例(21.5%)和 240 例(28.5%)在 30 天、90 天和 180 天内再次入院。30 天内再入院的主要原因为 PM 和败血症。在这 3 个时间范围内,这是最常见的原因。2018 年,30 天再入院导致的总住院费用为 410 万美元,住院天数为 1518 天。与索引住院相比,30 天再入院的患者Charlson 合并症指数评分较高,严重/极度功能丧失,肥胖和深静脉血栓形成。

结论

大约三分之一的 PM/DM 住院患者在 180 天内再次入院。再入院给医疗保健系统带来了重大的经济负担。PM 和败血症是再入院的主要原因。主要发现 • 大约三分之一的多发性肌炎(PM)/皮肌炎(DM)住院患者在 180 天内再次入院。 • PM 和败血症是再入院的主要原因。 • PM/DM 患者的再入院给医疗保健系统带来了重大的经济负担。 • 与索引住院相比,30 天再入院的患者 Charlson 合并症指数评分较高,严重/极度功能丧失,肥胖和深静脉血栓形成。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验